157 related articles for article (PubMed ID: 27596073)
1. Guidelines for Homology Modeling of Dopamine, Norepinephrine, and Serotonin Transporters.
Haddad Y; Heger Z; Adam V
ACS Chem Neurosci; 2016 Nov; 7(11):1607-1613. PubMed ID: 27596073
[TBL] [Abstract][Full Text] [Related]
2. Comparative modeling of the human monoamine transporters: similarities in substrate binding.
Koldsø H; Christiansen AB; Sinning S; Schiøtt B
ACS Chem Neurosci; 2013 Feb; 4(2):295-309. PubMed ID: 23421681
[TBL] [Abstract][Full Text] [Related]
3. Coordination of Na(+) by monoamine ligands in dopamine, norepinephrine, and serotonin transporters.
Xhaard H; Backström V; Denessiouk K; Johnson MS
J Chem Inf Model; 2008 Jul; 48(7):1423-37. PubMed ID: 18543980
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transporters.
Eshleman AJ; Nagarajan S; Wolfrum KM; Reed JF; Swanson TL; Nilsen A; Janowsky A
Psychopharmacology (Berl); 2019 Mar; 236(3):939-952. PubMed ID: 30397775
[TBL] [Abstract][Full Text] [Related]
5. Structure Modeling of the Norepinephrine Transporter.
Góral I; Łątka K; Bajda M
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31936154
[TBL] [Abstract][Full Text] [Related]
6. Human genetics and pharmacology of neurotransmitter transporters.
Lin Z; Madras BK
Handb Exp Pharmacol; 2006; (175):327-71. PubMed ID: 16722243
[TBL] [Abstract][Full Text] [Related]
7. Binding of the amphetamine-like 1-phenyl-piperazine to monoamine transporters.
Severinsen K; Kraft JF; Koldsø H; Vinberg KA; Rothman RB; Partilla JS; Wiborg O; Blough B; Schiøtt B; Sinning S
ACS Chem Neurosci; 2012 Sep; 3(9):693-705. PubMed ID: 23019496
[TBL] [Abstract][Full Text] [Related]
8. Putative drug binding conformations of monoamine transporters.
Ravna AW; Sylte I; Kristiansen K; Dahl SG
Bioorg Med Chem; 2006 Feb; 14(3):666-75. PubMed ID: 16216517
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous Multiple MS Binding Assays for the Dopamine, Norepinephrine, and Serotonin Transporters.
Neiens P; De Simone A; Höfner G; Wanner KT
ChemMedChem; 2018 Mar; 13(5):453-463. PubMed ID: 29451362
[TBL] [Abstract][Full Text] [Related]
10. Interrogating the Molecular Basis for Substrate Recognition in Serotonin and Dopamine Transporters with High-Affinity Substrate-Based Bivalent Ligands.
Andersen J; Ladefoged LK; Kristensen TN; Munro L; Grouleff J; Stuhr-Hansen N; Kristensen AS; Schiøtt B; Strømgaard K
ACS Chem Neurosci; 2016 Oct; 7(10):1406-1417. PubMed ID: 27425420
[TBL] [Abstract][Full Text] [Related]
11. Structure and localisation of drug binding sites on neurotransmitter transporters.
Ravna AW; Sylte I; Dahl SG
J Mol Model; 2009 Oct; 15(10):1155-64. PubMed ID: 19238460
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.
Eshleman AJ; Carmolli M; Cumbay M; Martens CR; Neve KA; Janowsky A
J Pharmacol Exp Ther; 1999 May; 289(2):877-85. PubMed ID: 10215666
[TBL] [Abstract][Full Text] [Related]
13. Monoamine transporters: structure, intrinsic dynamics and allosteric regulation.
Cheng MH; Bahar I
Nat Struct Mol Biol; 2019 Jul; 26(7):545-556. PubMed ID: 31270469
[TBL] [Abstract][Full Text] [Related]
14. α-PPP and its derivatives are selective partial releasers at the human norepinephrine transporter: A pharmacological characterization of interactions between pyrrolidinopropiophenones and high and low affinity monoamine transporters.
Maier J; Rauter L; Rudin D; Niello M; Holy M; Schmid D; Wilson J; Blough BE; Gannon BM; Murnane KS; Sitte HH
Neuropharmacology; 2021 Jun; 190():108570. PubMed ID: 33864800
[TBL] [Abstract][Full Text] [Related]
15. The antidepressant-sensitive dopamine transporter in Drosophila melanogaster: a primordial carrier for catecholamines.
Pörzgen P; Park SK; Hirsh J; Sonders MS; Amara SG
Mol Pharmacol; 2001 Jan; 59(1):83-95. PubMed ID: 11125028
[TBL] [Abstract][Full Text] [Related]
16. Interaction of antidepressants with the serotonin and norepinephrine transporters: mutational studies of the S1 substrate binding pocket.
Sørensen L; Andersen J; Thomsen M; Hansen SM; Zhao X; Sandelin A; Strømgaard K; Kristensen AS
J Biol Chem; 2012 Dec; 287(52):43694-707. PubMed ID: 23086945
[TBL] [Abstract][Full Text] [Related]
17. The external gate of the human and Drosophila serotonin transporters requires a basic/acidic amino acid pair for 3,4-methylenedioxymethamphetamine (MDMA) translocation and the induction of substrate efflux.
Sealover NR; Felts B; Kuntz CP; Jarrard RE; Hockerman GH; Lamb PW; Barker EL; Henry LK
Biochem Pharmacol; 2016 Nov; 120():46-55. PubMed ID: 27638414
[TBL] [Abstract][Full Text] [Related]
18. Focus on Human Monoamine Transporter Selectivity. New Human DAT and NET Models, Experimental Validation, and SERT Affinity Exploration.
Ortore G; Orlandini E; Betti L; Giannaccini G; Mazzoni MR; Camodeca C; Nencetti S
ACS Chem Neurosci; 2020 Oct; 11(20):3214-3232. PubMed ID: 32991141
[TBL] [Abstract][Full Text] [Related]
19. Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transporters.
Zhang S; Fernandez F; Hazeldine S; Deschamps J; Zhen J; Reith ME; Dutta AK
J Med Chem; 2006 Jul; 49(14):4239-47. PubMed ID: 16821783
[TBL] [Abstract][Full Text] [Related]
20. Computational identification of the binding mechanism of a triple reuptake inhibitor amitifadine for the treatment of major depressive disorder.
Xue W; Wang P; Tu G; Yang F; Zheng G; Li X; Li X; Chen Y; Yao X; Zhu F
Phys Chem Chem Phys; 2018 Feb; 20(9):6606-6616. PubMed ID: 29451287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
